PharmaLinea d.o.o.   Report issue

For profit
Founded: Ljubljana Slovenia (2018)
Status: No NME R&D (2018)

Organization Overview

First Clinical Trial
2018
NCT04093206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

PharmaLinea d.o.o. | PharmaLinea Ltd.

Active Ingredients

Drugs in Other Trials (4)

ferrous sulfate (1 trial)

fosfomycin (monurol) (1 trial)

iron (1 trial)

vitamin c (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 4